Skip to main content

Arthritis Brand Tylenol Recall Expanded At The End Of 2009

It is a bad year for Tylenol products, as earlier this year in 2009 Johnson and Johnson had to recall their children's version. On Tuesday, the company expanding a voluntary Tylenol recall for Arthritis Caplets due to consumer reports of a moldy smell, as well as reports of nausea and stomach pain.

According to a statement regarding the Tylenol recall on the Food and Drug Administration (FDA) Web site, J&J is recalling all product lots of the Arthritis Pain Caplet (100 count) bottles with the red EZ-Open Cap. Previously, the company had recalled five lots of the product, last month.

Johnson and Johnson said that the moldy odor results from trace amounts of a chemical called 2,4,6-tribromoanisole. That trace amount results, the company believes, from the breakdown of another chemical used to treat wooden pallets that transport and store packaging materials.

The Tylenol recall only affects the 100 count caplets as specifically noted above. All other Tylenol Arthritis pain products remain available.

The reported side effects of taking the affected caplets have, thus far, To date, the side effects have been non-serious and temporary. In addition to the above-mentioned symptoms, some have suffered vomiting and diarrhea.

Johnson and Johnson plans to move production to a new facility. It expects that it will re-introduce the Tylenol Arthritis Pain Caplets in 100 count bottles by January.

Reportedly, the earlier Children's Tylenol Recall was mostly about the possibility of overdosing. The blister package design, as well as the information on the blister package and on the blister and bottle cartons, was felt to be in some cases be confusing, which could lead to improper dosing.

Written by Michael Santo
HULIQ.com

Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.